AAAAAA
Results:
1-8
|
Results: 8
Authors:
Kavakli, K
Huseyinov, A
Coker, I
Aydinok, Y
Nisli, G
Citation: K. Kavakli et al., Intraleucocyte platelet-activating factor levels in desmopressin-treated patients with haemophilia A and von Willebrand disease, HAEMOPHILIA, 7(5), 2001, pp. 482-489
Authors:
Kavakli, K
Aydinok, Y
Karapinar, D
Balkan, C
Citation: K. Kavakli et al., DDAVP treatment in children with haemophilia B, BR J HAEM, 114(3), 2001, pp. 733-734
Authors:
Kavakli, K
Polat, A
Huseyinof, A
Nisli, G
Aydinok, Y
Citation: K. Kavakli et al., Plasma platelet-activating factor (PAF) levels and desmopressin response in children with hemophilia A and von Willebrand's disease, THROMB HAEM, 81(4), 1999, pp. 665-666
Authors:
Aydinok, Y
Coker, C
Kavakli, K
Polat, A
Nisli, G
Cetiner, N
Kantar, M
Cetingul, N
Citation: Y. Aydinok et al., Urinary zinc excretion and zinc status of patients with beta-thalassemia major, BIOL TR EL, 70(2), 1999, pp. 165-172
Authors:
Kavakli, K
Nisli, G
Kutukculer, N
Polat, A
Aydinok, Y
Oztop, S
Centingul, N
Citation: K. Kavakli et al., Long-term prophylaxis and immune parameters in haemophilia, J TROP PEDI, 45(2), 1999, pp. 122-123
Authors:
Kantar, M
Cetingul, N
Oniz, H
Aydinok, Y
Kavakli, K
Citation: M. Kantar et al., Skin toxicity after administration of low-dose cytarabine, MED PED ONC, 33(4), 1999, pp. 420-421
Authors:
Aydinok, Y
Nisli, G
Kavakli, K
Citation: Y. Aydinok et al., Alternate use of deferiprone and desferrioxamine in primary school children with thalassaemia major, BR J HAEM, 106(1), 1999, pp. 252-253
Authors:
Aydinok, Y
Nisli, G
Kavakli, K
Coker, C
Kantar, M
Cetingul, N
Citation: Y. Aydinok et al., Sequential use of deferiprone and desferrioxamine in primary school children with thalassaemia major in Turkey, ACT HAEMAT, 102(1), 1999, pp. 17-21
Risultati:
1-8
|